Mirari Cold Plasma is a modern medical technology that utilizes a cold plasma state — generating ions, activated molecules, and ultraviolet rays at safe levels — offering many breakthroughs in the treatment of dermatological conditions. Thanks to its multi-dimensional effects, Mirari is widely applied in treating acne, atopic dermatitis, psoriasis, rosacea, skin infections, as well as issues of aging, hyperpigmentation, or pigment disorders. In practical treatment protocols, the device is applied directly to the affected skin area with specific modes — for example: antibacterial action in acne and skin infections; anti-inflammatory effects and restoration of the skin barrier in atopic dermatitis; immune modulation and pigment balancing for cases of psoriasis or hyperpigmentation. Depending on the severity of the condition (mild, moderate, severe), treatment duration and frequency are adjusted accordingly, delivering noticeable results within just a few weeks.

The outstanding advantage of Mirari Cold Plasma lies in its strong antibacterial capability without inducing drug resistance, its regulation of immune responses and inflammation through cytokine control, while stimulating collagen production, promoting wound healing, and restoring skin structure and tone. More importantly, this technology does not cause thermal damage to healthy tissues, making it particularly safe and suitable for the elderly, children, and individuals with sensitive skin. With a solid scientific foundation, Mirari Cold Plasma continues to affirm its pioneering role in effectively supporting the treatment of modern dermatological conditions.

Mirari Cold Plasma is an advanced medical device that utilizes cold plasma technology — a low-energy state of matter containing ions, activated molecules, and ultraviolet rays at safe levels. This device has been recognized and widely applied in Vietnam as well as in many developed countries thanks to its outstanding effectiveness in supporting wound healing.

The primary applications of Mirari Cold Plasma focus on treating hard-to-heal wounds such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, arterial ulcers, post-surgical or skin graft wounds, and various types of burns at different severity levels.

The treatment method involves applying cold plasma directly to the wound area with customized modes suitable for the location and severity of the injury. Treatment duration and frequency are personalized based on each patient’s specific condition.

From a scientific perspective, Mirari Cold Plasma generates reactive oxygen and nitrogen species (NO, ROS) capable of killing bacteria — including drug-resistant strains — while disrupting biofilm membranes to reduce the risk of persistent infection. The device also effectively regulates inflammation by reducing pro-inflammatory cytokines such as TNF-α and increasing anti-inflammatory cytokines like IL-10, helping stabilize the wound-healing process. In addition, this technology stimulates granulation tissue and fibroblast proliferation, promotes angiogenesis, boosts collagen synthesis and epithelialization, thereby shortening healing time and minimizing poor scarring.

Most importantly, Mirari Cold Plasma operates safely, causes no thermal damage, and is suitable even for deep wounds, patients with poor circulation, or those with chronic conditions. Practical applications have shown that the device improves recovery rates, reduces pain, decreases inflammation, and prevents infectious complications — opening a highly effective, sustainable approach in modern medicine.

Mirari Cold Plasma is an advanced medical technology based on the principle of generating bioactive molecules such as nitric oxide (NO), reactive oxygen and nitrogen species (RONS), along with ultraviolet rays at levels safe for the human body. This enables the device to effectively support immune enhancement, which is particularly important for individuals with chronic illnesses, post-surgical patients, cancer patients, or those with compromised immune systems.

Mirari Cold Plasma is widely applied in various clinical situations, such as: supporting immune enhancement for cancer patients to help reduce fatigue and increase resistance; recovery after prolonged viral infections or post-chemotherapy/radiotherapy treatments; as well as improving overall health for the elderly, patients with diabetes, cardiovascular conditions, and individuals prone to recurrent infections. The treatment process involves applying cold plasma directly to designated areas of the body, with a personalized protocol based on the severity of the condition (mild, moderate, severe). Each session usually lasts from 15 to 30 minutes, with a frequency of 1 to 3 times per day, depending on the medical condition.

The mechanism of action of Mirari Cold Plasma is to stimulate and regulate the multi-layered immune system by enhancing the synthesis of NO and RONS. This helps promote the activity of immune cells such as macrophages and T lymphocytes, while balancing immune signaling molecules, reducing chronic inflammation, and controlling the risk of secondary infections. In addition, the device stimulates new tissue growth, improves microcirculation, and restores cellular function, enabling the body to better resist pathogens.

Numerous clinical and practical studies have shown that Mirari Cold Plasma helps improve quality of life, shorten recovery time, reduce infectious complications, and effectively support modern immunotherapy methods. This is a safe, non-invasive solution that aligns with today’s advanced rehabilitation trends.

Mirari Cold Plasma is an advanced medical technology solution, notable for its safe, effective, and non-invasive pain-relief support in treating conditions related to the musculoskeletal system, nervous system, and post-surgical recovery. The device operates on the principle of generating a cold plasma state — containing ions, activated molecules, and ultraviolet rays at safe levels — providing multi-dimensional effects on tissues.

The clinical applications of Mirari Cold Plasma are highly diverse: The device is widely used to support pain relief from osteoarthritis (back pain, knee pain, elbow pain, etc.), neuropathic pain (post-herpetic neuralgia, diabetic neuropathy), post-surgical pain (such as after joint replacement, tooth extraction, soft-tissue surgery), as well as chronic pain of unknown origin (chronic lower back pain, fibromyalgia) and pain syndromes caused by inflammation or immune disorders.

The treatment method involves applying Mirari Cold Plasma directly to the skin or tissue in pain, following protocols tailored for each disease group and pain level (mild, moderate, severe). Each session typically lasts 15–30 minutes, with time and frequency adjusted according to the patient’s condition.

The pain-relief effectiveness of Mirari Cold Plasma is based on solid biological mechanisms: The device helps reduce the production of inflammatory cytokines such as IL-6 and TNF-α, enhances the synthesis of anti-inflammatory factors (IL-10, TGF-β), while stimulating fibroblasts and improving blood circulation in the affected area. For neuropathic pain, cold plasma regulates nociceptor activity, decreases central and peripheral nerve sensitivity, promotes the release of natural endogenous opioids, and facilitates nerve tissue regeneration. Clinical studies have shown rapid pain relief, reduced use of analgesics (including opioids), accelerated motor function recovery, and improved quality of life for patients.

Mirari Cold Plasma is an advanced medical technology that utilizes cold plasma — a state of matter containing electrically charged ions, activated molecules, and ultraviolet rays at levels safe for skin and living tissues. This device offers an effective solution for post-aesthetic surgery care, promoting faster recovery and enhancing aesthetic outcomes.

In post-surgical aesthetic treatments, Mirari Cold Plasma is widely used for procedures such as rhinoplasty, blepharoplasty, facelifts, liposuction and body contouring, skin grafts, facial fillers, and scar management. The device works by directing cold plasma directly onto the skin or surgical site, with treatment modes tailored to each type of injury and varying degrees of swelling or inflammation.

The biological mechanisms of Mirari Cold Plasma include strong antimicrobial action through reactive oxygen and nitrogen species (ROS, NO), reduction of inflammation and edema, as well as stimulation of collagen synthesis, epithelialization, and angiogenesis. This accelerates wound healing, reduces swelling and pain effectively without causing thermal damage to tissues. Additionally, the technology helps regulate hyperpigmentation and limits hypertrophic scarring after surgery, delivering natural, safe, and long-lasting aesthetic results.

Thanks to its superior ability to control inflammation, enhance tissue regeneration, and ensure absolute safety, Mirari Cold Plasma has become a preferred choice in modern aesthetic surgery centers, contributing to higher service quality and increased patient satisfaction.